{
  "ptid_time": "127_S_2213_2012-12-10",
  "img_path": "/data/qiuhui/data/adni/images/127_S_2213/2012-12-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 34,509 mm³, 6.6% below the reference mean. With a Z-score of -0.18 (42.9th percentile), this represents normal volume ; hippocampal volume measures 5,568 mm³, 14.3% below the reference mean. With a Z-score of -1.14 (12.6th percentile), this represents mild atrophy; whole brain volume measures 828,119 mm³, 10.8% below the reference mean. With a Z-score of -1.29 (9.8th percentile), this represents mild atrophy. ",
  "text_data": "Age is 84.3 years. Gender is Female. Education: 14 years. MMSE: 30.0. MoCA: 24.0. Logical Memory: 10.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.39 SUVR (significant elevated); Amyloid beta: 1058.00 pg/mL (normal ); Total tau: 307.90 pg/mL (normal ); Phosphorylated tau: 29.86 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal and whole brain volumes show mild atrophy (Z-scores -1.14 and -1.29, respectively), which is concerning for neurodegeneration. However, cognitive testing (MMSE 30, MoCA 24) suggests only mild cognitive impairment (MCI), not dementia, and biomarker data (normal Aβ, elevated AV45 but normal T-tau and only mildly elevated P-tau) are ambiguous for Alzheimer’s pathology.  \n\n**Diagnosis:** **MCI**  \n**Confidence:** **Medium** (due to conflicting biomarkers and preserved cognition despite atrophy)",
  "timestamp": "2025-07-26T13:11:33.802694"
}